Understanding how Higd2a and OXPHOS remodeling interact in different tissues could open new therapeutic strategies for optimizing mitochondrial health in conditions such as metabolic disorders and alcohol-induced mitochondrial dysfunction. This evidence concerns the gene HIGD2A and metabolic disease.